BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

995 related articles for article (PubMed ID: 21079042)

  • 1. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.
    Korkmaz B; Horwitz MS; Jenne DE; Gauthier F
    Pharmacol Rev; 2010 Dec; 62(4):726-59. PubMed ID: 21079042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
    Korkmaz B; Moreau T; Gauthier F
    Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of neutrophil elastase, proteinase 3, and cathepsin G activities using intramolecularly quenched fluorogenic substrates.
    Korkmaz B; Attucci S; Epinette C; Pitois E; Jourdan ML; Juliano L; Gauthier F
    Methods Mol Biol; 2012; 844():125-38. PubMed ID: 22262439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans.
    Pham CT; Ivanovich JL; Raptis SZ; Zehnbauer B; Ley TJ
    J Immunol; 2004 Dec; 173(12):7277-81. PubMed ID: 15585850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
    Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
    Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local structural plasticity of the
    Herdendorf TJ; Stapels DAC; Rooijakkers SHM; Geisbrecht BV
    J Biol Chem; 2020 May; 295(22):7753-7762. PubMed ID: 32303641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).
    Korkmaz B; Lesner A; Letast S; Mahdi YK; Jourdan ML; Dallet-Choisy S; Marchand-Adam S; Kellenberger C; Viaud-Massuard MC; Jenne DE; Gauthier F
    Semin Immunopathol; 2013 Jul; 35(4):411-21. PubMed ID: 23385856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin C role in inflammatory gastroenterological, renal, rheumatic, and pulmonary disorders.
    Aghdassi AA; Pham C; Zierke L; Mariaule V; Korkmaz B; Rhimi M
    Biochimie; 2024 Jan; 216():175-180. PubMed ID: 37758158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare CTSC mutation in Papillon-Lefèvre Syndrome results in abolished serine protease activity and reduced NET formation but otherwise normal neutrophil function.
    Sanchez Klose FP; Björnsdottir H; Dahlstrand Rudin A; Persson T; Khamzeh A; Sundqvist M; Thorbert-Mros S; Dieckmann R; Christenson K; Bylund J
    PLoS One; 2021; 16(12):e0261724. PubMed ID: 34932608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Library of Phosphonic-Type Inhibitors of Human Neutrophil Elastase.
    Torzyk-Jurowska K; Ciekot J; Winiarski L
    Molecules; 2024 Mar; 29(5):. PubMed ID: 38474630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3.
    Craciun I; Fenner AM; Kerns RJ
    Glycobiology; 2016 Jul; 26(7):701-709. PubMed ID: 26850997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses.
    Sørensen OE; Clemmensen SN; Dahl SL; Østergaard O; Heegaard NH; Glenthøj A; Nielsen FC; Borregaard N
    J Clin Invest; 2014 Oct; 124(10):4539-48. PubMed ID: 25244098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Neutrophil Elastase and Cathepsin G As a New Approach to the Treatment of Psoriasis: From Fundamental Biology to Development of New Target-Specific Drugs.
    Krasavin MY; Gureev MA; Garabadzhiu AV; Pashkin AY; Zhukov AS; Khairutdinov VR; Samtsov AV; Shvets VI
    Dokl Biochem Biophys; 2019 Jul; 487(1):272-276. PubMed ID: 31559596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the azurocidin, proteinase 3, and neutrophil elastase genes. Implications for inflammation and vasculitis.
    Jenne DE
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S147-54. PubMed ID: 7952651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo.
    Glenthøj A; Nickles K; Cowland J; Borregaard N
    PLoS One; 2015; 10(5):e0125483. PubMed ID: 25945506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended Cleavage Specificity of Human Neutrophil Elastase, Human Proteinase 3, and Their Distant Ortholog Clawed Frog PR3-Three Elastases With Similar Primary but Different Extended Specificities and Stability.
    Fu Z; Thorpe M; Akula S; Chahal G; Hellman LT
    Front Immunol; 2018; 9():2387. PubMed ID: 30459762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
    Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
    J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elastase activity reporter for Electronic Paramagnetic Resonance (EPR) and Overhauser-enhanced Magnetic Resonance Imaging (OMRI) as a line-shifting nitroxide.
    Jugniot N; Duttagupta I; Rivot A; Massot P; Cardiet C; Pizzoccaro A; Jean M; Vanthuyne N; Franconi JM; Voisin P; Devouassoux G; Parzy E; Thiaudiere E; Marque SRA; Bentaher A; Audran G; Mellet P
    Free Radic Biol Med; 2018 Oct; 126():101-112. PubMed ID: 30092349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss-of-function mutations in cathepsin C in two families with Papillon-Lefèvre syndrome are associated with deficiency of serine proteinases in PMNs.
    de Haar SF; Jansen DC; Schoenmaker T; De Vree H; Everts V; Beertsen W
    Hum Mutat; 2004 May; 23(5):524. PubMed ID: 15108292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
    Korkmaz B; Jenne DE; Gauthier F
    Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.